| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/13/2023 | — | Maxim Group | Downgrades | Buy → Hold | |
| 04/26/2023 | 1145.67% | HC Wainwright & Co. | $7 → $9 | Maintains | Buy |
| 02/01/2023 | 868.86% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 12/09/2022 | 868.86% | HC Wainwright & Co. | → $7 | Initiates Coverage On | → Buy |
| 12/08/2022 | 453.63% | Maxim Group | → $4 | Initiates Coverage On | → Buy |
What is the target price for Blue Water Biotech (BWV)?
The latest price target for Blue Water Biotech (NASDAQ: BWV) was reported by Maxim Group on September 13, 2023. The analyst firm set a price target for $0.00 expecting BWV to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Blue Water Biotech (BWV)?
The latest analyst rating for Blue Water Biotech (NASDAQ: BWV) was provided by Maxim Group, and Blue Water Biotech downgraded their hold rating.
When is the next analyst rating going to be posted or updated for Blue Water Biotech (BWV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Blue Water Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Blue Water Biotech was filed on September 13, 2023 so you should expect the next rating to be made available sometime around September 13, 2024.
Is the Analyst Rating Blue Water Biotech (BWV) correct?
While ratings are subjective and will change, the latest Blue Water Biotech (BWV) rating was a downgraded with a price target of $0.00 to $0.00. The current price Blue Water Biotech (BWV) is trading at is $0.72, which is out of the analyst's predicted range.